Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study

CONCLUSIONS: This model integrating simplified geriatric assessment can risk-stratify older patients with DLBCL and identify those who are highly vulnerable to standard dose-intensity chemoimmunotherapy.PMID:38287501 | DOI:10.3904/kjim.2023.265
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Source Type: research